Last reviewed · How we verify
NCT06245369: SWITCH
SWITCH Diets Study: Self-monitoring With Internet Technology to Choose Healthy Diets
NA trial testing learning modules (within app) in Overweight and Obesity in 106 participants. Completed in 18 March 2025.
14 February 2025
Quick facts
| Lead sponsor | University of South Carolina |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 106 |
| Start date | 15 April 2024 |
| Primary completion | 14 February 2025 |
| Estimated completion | 18 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- learning modules (within app)
- SWITCH app (self-regulation features) - Experimental
- SWITCH app (self-regulation features) - Comparator
Conditions studied
- Overweight and Obesity — all drugs for Overweight and Obesity →
- Pre-diabetes — all drugs for Pre-diabetes →
Sponsor
University of South Carolina
Who can join
Adults 18 to 65, any sex, with Overweight and Obesity or Pre-diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of the Self-monitoring With Internet Technology to Choose Healthy Diets (SWITCH) study is to examine a 12-week remotely delivered program designed to help adults adopt a healthy dietary lifestyle and lose weight in a diverse cohort of adults with overweight/obesity. The intervention uses a self-determination theory framework to provide a deeper understanding of the factors that influence dietary behavior within the context of tracking. This study incorporates autonomy-supportive strategies to encourage participants to feel more in control of their dietary choices and will provide information and resources to boost participant's competence in achieving their dietary goals. The intervention includes weekly learning modules to support healthy eating and weight loss and daily dietary tracking with visual feedback, all accessible within the SWITCH app.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06245369
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
- NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other University of South Carolina trials
Trials by the same sponsor.
- NCT06469749 — Theory-based Social Media Intervention for Non-medical Use of Prescription Opioids in Young Adults · NA · not yet recruiting
- NCT07340580 — Implementation Facilitation of Exercise is Medicine Greenville · NA · not yet recruiting
- NCT07518407 — Dietary Insights and Nutritional Education in Adults on GLP-1 Therapy · NA · not yet recruiting
- NCT07340099 — Church Implementation of a Social Support Intervention to Increase Physical Activity in Older African American Adults · NA · not yet recruiting
- NCT06024317 — Leveraging Community Health Workers and a Digital Health System to Improve the Timeliness of Child Well Visits · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06245369 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of South Carolina
- Last refreshed: 21 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06245369.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing